JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
Tax Provision
JCR Pharmaceuticals Co Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Tax Provision
-¥2.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-15%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Tax Provision
¥30.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Tax Provision
-¥12.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Tax Provision
-¥21.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Tax Provision
-¥118.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-17%
|
|
Astellas Pharma Inc
TSE:4503
|
Tax Provision
-¥35.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
See Also
What is JCR Pharmaceuticals Co Ltd's Tax Provision?
Tax Provision
-2.1B
JPY
Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's Tax Provision amounts to -2.1B JPY.
What is JCR Pharmaceuticals Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-15%
Over the last year, the Tax Provision growth was -19%. The average annual Tax Provision growth rates for JCR Pharmaceuticals Co Ltd have been -23% over the past three years , -30% over the past five years , and -15% over the past ten years .